Literature DB >> 155493

Effect of mithramycin on bone beta-glucuronidase and resorption.

D T Kiang.   

Abstract

Mithramycin suppresses bone resorption. Its effect on the synthesis and release of beta-glucuronidase (a referent for lysosomal enzymes) in mouse calvarial explants was studied in an in vitro culture system. A newly described medium (designated as KT medium) was introduced in this specific study. Mithramycin initially inhibited the release of beta-glucuronidase into the medium and resulted in an ultimate accumulation of this enzyme in the bone. These results suggest that inhibition of bone resorption by mithramycin may be attributed to interference in release of lysosomal enzymes from bone cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 155493     DOI: 10.1007/bf02013260

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


  15 in total

1.  A note on the determination of serum beta-glucuronidase activity.

Authors:  C H PLAICE
Journal:  J Clin Pathol       Date:  1961-11       Impact factor: 3.411

2.  Studies on the mode of action of excess of vitamin A. 6. Lysosomal protease and the degradation of cartilage matrix.

Authors:  H B FELL; J T DINGLE
Journal:  Biochem J       Date:  1963-05       Impact factor: 3.857

3.  Purification of the hyperglycemic-glycogenolytic factor from insulin and from gastric mucosa.

Authors:  E W SUTHERLAND; C F CORI
Journal:  J Biol Chem       Date:  1949-09       Impact factor: 5.157

4.  Inhibition by calcitonin of bone resorption induced in vitro by vitamin A.

Authors:  J J Reynolds
Journal:  Proc R Soc Lond B Biol Sci       Date:  1968-05-14

5.  Inhibitory actions of calcitonin on resorbing bone explants in culture and on their release of lysosomal hydrolases.

Authors:  G Vaes
Journal:  J Dent Res       Date:  1972 Mar-Apr       Impact factor: 6.116

6.  Mithramycin treatment of hypercalcemia.

Authors:  C P Perlia; N J Gubisch; J Wolter; D Edelberg; M M Dederick; S G Taylor
Journal:  Cancer       Date:  1970-02       Impact factor: 6.860

7.  A sensitive in vitro method for studying the induction and inhibition of bone resorption.

Authors:  J J Reynolds; J T Dingle
Journal:  Calcif Tissue Res       Date:  1970

8.  Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma.

Authors:  F R Singer; R M Neer; T M Murray; H T Keutmann; L J Deftos; J T Potts
Journal:  N Engl J Med       Date:  1970-09-17       Impact factor: 91.245

9.  Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease.

Authors:  V Parsons; M Baum; M Self
Journal:  Br Med J       Date:  1967-02-25

10.  On the mechanisms of bone resorption. The action of parathyroid hormone on the excretion and synthesis of lysosomal enzymes and on the extracellular release of acid by bone cells.

Authors:  G Vaes
Journal:  J Cell Biol       Date:  1968-12       Impact factor: 10.539

View more
  2 in total

1.  Identification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin.

Authors:  E Beaulieu; L Green; L Elsby; Z Alourfi; E F Morand; D W Ray; R Donn
Journal:  Clin Exp Immunol       Date:  2010-11-19       Impact factor: 4.330

2.  Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes.

Authors:  Abdelhamid Liacini; Judith Sylvester; Wen Qing Li; Muhammad Zafarullah
Journal:  Arthritis Res Ther       Date:  2005-04-04       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.